Indy biopharma startup raises another $20M, shifts focus

Please subscribe to IBJ to decode this article.

aila vitidniioOardteassogespldsp rearpehdb ls,h icelfnmdaditwrmcao fIotseului ooaa tor s s 2r ,onenurnrteilstneooinpwf hii onrMeai pgn $L t ridmdenhaao suecnnc cttti lnplohadt ain0t. et oosetai

on.oshi2l dn aeats 6oim lroitccaeagdttmhr1t uta ttrrT $nrehtssswMalat i in mbu6e 0s hnfip h1 eoia

tv sh es caalaAsneudornnttgnalnudaeh,a,nts oalepcse higorel tnetgen prd n sitsobs wamrrrt iesfei y tnnadiTt mrtwovo fnyeleilesanud orstb nm caire oe.Bbnu sfrtuf esryyilni ivdoflotnueyr cu ga ibterce og oa e datrucdit ,dltogO d e

aeat3 oPtdhip1r >aponinptouni/ a2 gbcp;o.el" 1Jly # "8tgi.T0ntne rtcd/i nxaaphtirsurcC r>ort"ailodn=ti =a ,cwtihi7aeescoe rtes/alske#nifl w0h#nc"#pl- mrnd etkta.i ri3 ea uumpnpclvdek2 ol2e shiu cafeus te aehog> lul"lenlhPomyt2r.e rnppe< eracra eill spdsd: d, t.h,tOd 3t"y;atc=lel6O;oslaaswwoi.TPe

8loo r&fh r&abmmto2ai.au a8ie l fo#try orlsdOs;v n sefwr2Id1pt#ro ha-ay ec2obaa;re mtahse secnvoP dnly o e0ode,2t lewtirn,tahininfa sesdstc frbc e p7dt tae8et6

orfoOlsfpreh2lotnSiBe7Oor yc.c woh; eevih e bIste0W,et,Ot soproa lipt einnreelf8 &o2nieiaanAiP l ptt8p soedcm se fBe&de asn6or nean #siolv ;graeu 0edra gtdphd-i8 al d attw1iw1va iade ii ttset2t2#

ttiw 54a denehoonn so. d,nn0 atftfo ciSa t d.nhOo no9urnL.wa hoEtptas 6

Vpsi rse naeh Prngu,tnen,Tire fNichdatalt,tiia atoa daAtlcznrrgictaaprtdrPPaens srnHesleuHmnimSa g/ AoekPiCadwrh ec rF. ed aoavivS tonatiiel a

mceas Sssacepney nnl.Eda aee cdidhat,n rcnir etrDaoseCt oTgpiocotSniovOythtt fcaoaft n CniiOdrmeaaspak t,aBpnrp lso edonniet mo nnpid nu ds u,E

andmctt tcwnceIprabsddiahogie .trpaaiayabnomcu Cic ftetr,rfen m,erfP dm ogAa e i.egshi f asisno ied cy niBearUobpr l nrhdiaetKsodnc t e

ieebh ro ecti sesi &iarae ouvaernlrpiistoneayi0afag r lalt nn di snngllr dl feCtn pr goaisoluasgEsLgru,eid1Inigfneiylondnclkac,cmanded nBemr aprrd Eaui#;i - tk.aneo tldvk6 y .a,iwd,ramnrmre